• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,664.21 -999.79
( -1.29%)
Global Indices
Nasdaq
49,249.13 -82.20
(-0.17%)
Dow Jones
7,185.72 56.32
(0.79%)
Hang Seng
59,744.07 603.84
(1.02%)
Nikkei 225
10,387.94 -69.07
(-0.66%)
Forex
USD-INR
94.05 0.29
(0.31%)
EUR-INR
109.99 0.01
(0.01%)
GBP-INR
126.84 0.17
(0.14%)
JPY-INR
0.59 0.00
(0.16%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
99.2482659
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
89.06
388680.27
EPS(TTM)
Face Value()
Div & Yield %
18.19
1
0.99
 

KTM AG raises refinancing loan of EUR 550 million
Feb 27,2026

Bajaj Mobility AG announced that KTM AG has successfully secured a loan to refinance its existing debt with Bajaj Auto International Holdings B.V.

As part of last year's restructuring, Bajaj Auto International Holdings B.V. provided KTM AG with a loan of EUR 450 million in May 2025 to finance the restructuring plan quota. The current refinancing loan agreement is granted by an international banking consortium and has a total volume of EUR 550 million. The loan is unsecured, has a 5-year term, and bears interest in the low to mid-single-digit percentage range.

During the term of the loan agreement, KTM AG is subject to market-standard restrictions on dividend distributions. With the signing of this loan agreement, the refinancing measures of KTM AG will be completed.

KTM AG is a wholly owned subsidiary of Bajaj Mobility AG and thereby, a step-down subsidiary of Bajaj Auto in Austria.

The shares of Bajaj Mobility AG are listed on the SIX Swiss Exchange and Vienna Stock Exchange.